Početna › Difuzni veliki B-stanični limfom › Ohio › Cincinnati
Kliničke studije za Difuzni veliki B-stanični limfom u gradu Cincinnati, OH
11 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Cincinnati i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
U tijeku regrutacijaFaza 2
- Oncology Hematology Care - Kenwood, Cincinnati
- University of Cincinnati Medical Center, Cincinnati
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
U tijeku regrutacijaOpažajna studija
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
U tijeku regrutacijaFaza 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi udaljenosti
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
U tijeku regrutacijaFaza 3
- Oncology_Hematology Care Clinical Trials, LLC (OHC) ( Site 8002), Cincinnati
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
U tijeku regrutacijaFaza 2/3
- Saint Elizabeth Medical Center Edgewood ( Site 0165), Edgewood · 8 mi udaljenosti
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
U tijeku regrutacijaFaza 2
- University of Cincinnati Medical Center ( Site 0156), Cincinnati
- Saint Elizabeth Medical Center Edgewood ( Site 0141), Edgewood · 8 mi udaljenosti
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
U tijeku regrutacijaFaza 3
- Oncology Hematology Care Clinical Trials, Cincinnati
- University of Cincinnati, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
- University of Cincinnati Medical Center, Cincinnati
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
U tijeku regrutacijaFaza 1
- University of Cincinnati, Cincinnati
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
U tijeku regrutacijaFaza 1/2
- University of Cincinnati, Cincinnati
Studije za Difuzni veliki B-stanični limfom u drugim gradovima
- New York City, NY21 studija
- Baldwin Park, CA19 studija
- Chicago, IL18 studija
- Houston, TX17 studija
- Los Angeles, CA17 studija
- Boston, MA16 studija
- Milwaukee, WI16 studija
- Nashville, TN15 studija
- Portland, OR15 studija
- Philadelphia, PA15 studija
- Durham, NC14 studija
- Dallas, TX13 studija
Ostale studije u gradu Cincinnati
- Nemikrocelularni karcinom pluća35 studija
- Rak (sve vrste)27 studija
- Rak dojke25 studija
- Srčano zatajenje24 studija
- Kolorektalni rak21 studija
- Akutna mijeloična leukemija20 studija
- Metastatski karcinom20 studija
- Rak jajnika19 studija
- Rak pluća19 studija
- Debljina19 studija
- Rak prostate18 studija
- Multipli mijelom17 studija
Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.